We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




No Standard Treatment for Extreme Premature Babies

By HospiMedica International staff writers
Posted on 18 May 2015
A new study reveals that hospital practices vary widely in initiating active treatment in extremely preterm infants.

Researchers at the University of Iowa (Iowa City, USA), Wayne State University (Detroit, MI, USA), and other institutions conducted a study involving infants born between April 2006 and March 2011 at 24 hospitals. More...
Excluding infants with congenital anomalies, 4,987 babies born before reaching 27 weeks of gestation were included in the analysis. Of these, 4,329 babies received active treatment, and outcomes were known for 4,704; active treatment was defined as any potentially lifesaving intervention administered after birth.

The results showed that the overall rates of active treatment ranged from 22.1% among infants born at 22 weeks of gestation to 99.8% among those born at 26 weeks of gestation. Active treatments included surfactant therapy, tracheal intubation, ventilatory support, parenteral nutrition, epinephrine, or chest compressions. Babies who did not receive active treatment tended to be small for their age, have one-minute Apgar scores of 3 or lower, and were less likely to have antenatal glucocorticoids or have been delivered by cesarean section.

The researchers also assessed survival and survival without severe neurological impairment once the babies reached 18–22 months of corrected age. Babies born at 26 weeks demonstrated an 81.4% survival rate, and a 75.6% rate of survival without severe impairment. For 22-week-old babies who were given active treatment, the rate of survival was 23.1%, the rate of survival without severe impairment was 15.4%, and the rate of survival without severe or moderate impairment was 9%. The study was published on May 7, 2015, in the New England Journal of Medicine (NEJM).

“Sometimes tiny babies with zero chance of surviving show signs of life at birth, and may be able to breathe for a short time if put in an incubator and hooked up to a breathing machine and intravenous treatments,” said study coauthor professor of pediatrics Edward Bell, MD. “But even so, if it's a baby that doesn't have a chance, we don't want to put the baby and the family through the discomfort. These are very difficult decisions and they need to be made on a case-by-case basis by the families and physicians.”

An estimated 15 million babies are born too early every year, and almost one million of them die each year due to complications of preterm birth. Many survivors face a lifetime of disability, including learning disabilities and visual and hearing problems. Globally, prematurity is the leading cause of death in children under the age of 5. And in almost all countries with reliable data, preterm birth rates are increasing. More than three-quarters of premature babies can be saved with feasible, cost-effective care, such as antenatal steroid injections to strengthen the babies’ lungs and antibiotics to treat newborn infections.

Related Links:

University of Iowa
Wayne State University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.